TGFB1 and neoplasm: In conclusion, our research found that MTE enhanced the anti-tumor T-cell response both in mice and patients, and reversed the tumor microenvironment’s immunosuppressive state through inhibition of TGF-β1 secretion and PD-L1 expression in tumor cells, and inhibition of Treg differentiation.